Drug combo tested to fight lung cancer in the brain
NCT ID NCT04964960
Summary
This study tested whether adding the drug pembrolizumab to standard chemotherapy could help patients with a type of lung cancer that had spread to their brain but wasn't causing symptoms. The goal was to see if this approach could control the cancer in the brain and body, help patients live longer, and maintain their quality of life. The trial was stopped early after enrolling only 3 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky, Markey Cancer Center
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.